Concentra Group Holdings Parent, INC

Concentra Group Holdings Parent, Inc. announces a consulting agreement with Dr. John R. Anderson following his retirement as Chief Medical Officer.

Concentra Group Holdings Parent, Inc. announced robust first-quarter 2026 financial results, including a 13.7% revenue increase and raised full-year guidance.

Concentra Group Holdings Parent, Inc. successfully concluded its 2026 annual meeting with shareholders electing three directors and ratifying its independent auditor.

Concentra Group Holdings Parent, Inc. announced the upcoming retirement of its Chief Medical Officer, Dr. John Anderson, effective December 31, 2026, after 33 years with the company.

Concentra Group Holdings Parent, Inc. announced robust financial results for Q4 and full-year 2025, exceeding guidance and providing an optimistic outlook for 2026.

Concentra Group Holdings Parent, Inc. announced preliminary unaudited financial results for Q4 and full year 2025, exceeding guidance, and provided a strong 2026 outlook.

Concentra Group Holdings reported strong Q1 2026 growth with revenue rising 13.7% to $569.6 million, driven by increased patient volumes and strategic acquisitions.

Concentra Group Holdings Parent, Inc. announced robust revenue growth and strategic acquisitions in its Q3 2025 report, alongside a new share repurchase program and dividend declaration.

Concentra Group Holdings Parent, Inc. reported significant revenue growth in Q2 2025, driven by strategic acquisitions, despite a decline in net income due to increased interest expenses and acquisition-related costs.

Concentra Group Holdings Parent, Inc. announces its Q1 2025 financial results, highlighting revenue growth and strategic acquisitions.

Concentra Group Holdings Parent reports a 3.3% increase in revenue for the third quarter of 2024, driven by higher revenue per visit, following its initial public offering in July.

Concentra Group Holdings Parent, a leading occupational health services provider, released its second quarter 2024 financial results, showing a revenue increase and operational changes following its recent IPO.

Occupational health leader Concentra Group Holdings Parent, Inc. reports significant revenue and Adjusted EBITDA growth in its 2025 annual filing, driven by strategic acquisitions and organic expansion.

Concentra Group Holdings Parent, Inc. releases its 2024 Form 10-K, highlighting financial performance, strategic initiatives, and the acquisition of Nova Medical Centers.

Robert A. Ortenzio, a Director at Concentra Group Holdings Parent, Inc., reported a significant sale of common stock.

Robert A. Ortenzio, a Director at Concentra Group Holdings Parent, Inc., reported a sale of 130,000 shares of common stock for approximately $3.25 million.

Robert A. Ortenzio, a Director at Concentra Group Holdings Parent, Inc., reported a significant transaction involving the acquisition of common stock.

Concentra Group Holdings Parent, Inc. CEO William Keith Newton reported a gift of 89,081 common shares to a beneficiary trust.

Timothy F. Ryan, Concentra's EVP & Chief Legal Counsel, disposed of 5,903 shares of common stock to cover tax liabilities from restricted stock vesting.

Concentra Group Holdings Parent, Inc.'s COO, Michael D. Rhine, disposed of 3,935 shares of common stock to cover tax obligations related to restricted stock vesting.

Concentra Group Holdings Parent, Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, executive compensation, and auditor ratification, alongside detailed corporate governance and compensation disclosures.

Concentra Group Holdings Parent, Inc. will hold its annual stockholders meeting virtually on May 1, 2025, to vote on director elections, executive compensation, and auditor ratification.

Concentra Group Holdings Parent, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on May 1, 2025, to vote on director elections, executive compensation, and other key proposals.

Concentra Group Holdings Parent, Inc. is pursuing an initial public offering to repay intercompany debt to Select Medical Corporation.

Concentra Group Holdings Parent, a subsidiary of Select Medical Corporation, has filed an S-1/A form with the SEC for its initial public offering, planning to use the proceeds to repay debt owed to Select Medical.

Concentra Group Holdings Parent, a subsidiary of Select Medical Corporation, has filed an S-1 registration statement for an initial public offering (IPO) of its common stock, with plans to list on the New York Stock Exchange under the ticker symbol 'CON'.

Robert A. Ortenzio updated his beneficial ownership in Concentra Group Holdings Parent, Inc., disclosing new restricted stock grants and a Rule 10b5-1 trading plan.

The Estate of Rocco A. Ortenzio has filed an exit amendment to its Schedule 13D, reporting a reduction in its beneficial ownership of Concentra Group Holdings Parent, Inc. common stock to below 5% following internal trust transfers.

Robert A. Ortenzio, a key insider, has increased his beneficial ownership in Concentra Group Holdings Parent, Inc. to approximately 6.4% of outstanding common stock following a distribution from a family trust.

Vanguard Portfolio Management has reported beneficial ownership of 5.32% of Concentra Group Holdings Parent Inc.'s common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Concentra Group Holdings Parent Inc. following an internal realignment.

T. Rowe Price Associates, Inc. has disclosed an increased beneficial ownership of 13.1% in Concentra Group Holdings Par common stock as of December 31, 2025.

T. Rowe Price Associates, Inc. has increased its beneficial ownership in Concentra Group Holdings Par to 13.4% of common stock, holding over 17 million shares.

T. Rowe Price Investment Management, Inc. has reported a beneficial ownership of 4.9% in Concentra Group Holdings PAR common stock as of September 30, 2025.

The Vanguard Group has filed an amended Schedule 13G, revealing a beneficial ownership of 10.28% in Concentra Group Holdings Parent Inc.'s Common Stock.